Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
Current Medical Research and Opinion|May 19, 2005
Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trialBaojin Zhu, Sandra L Tunis, Zhongyun Zhao, et al.
Journal of Affective Disorders|May 22, 2007
Effect of comorbid anxiety on treatment response in bipolar depressionMauricio Tohen, Joseph Calabrese, Eduard Vieta, et al.
The American Journal of Psychiatry|October 2, 2015
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in DepressionD Jeffrey Newport, Linda L Carpenter, William M McDonald, et al.
The American Journal of Psychiatry|January 5, 2021
Neuroimaging Biomarkers in SchizophreniaNina V Kraguljac, William M McDonald, Alik S Widge, et al.
Current Medical Research and Opinion|September 12, 2007
Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine toolsJamie Karagianis, Michael Rosenbluth, Mauricio Tohen, et al.
Bipolar Disorders|October 20, 2019
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 studyWillie R Earley, Maria V Burgess, Barbara Khan, et al.
Journal of Affective Disorders|July 28, 2007
The empirical redefinition of the psychometric criteria for remission in bipolar disorderMichael Berk, Felicity Ng, Wei V Wang, et al.
The Journal of Clinical Psychiatry|September 26, 2009
Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled studyJohn P Houston, Mauricio Tohen, Elisabeth K Degenhardt, et al.
Journal of Psychiatric Research|June 15, 2010
Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodesJohn P Houston, Terence A Ketter, Michael Case, et al.
Bipolar Disorders|May 29, 2016
Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD studyElizabeth D Ballard, Jennifer L Vande Voort, David A Luckenbaugh, et al.
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
Current Medical Research and Opinion|May 19, 2005
Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trialBaojin Zhu, Sandra L Tunis, Zhongyun Zhao, et al.
Journal of Affective Disorders|May 22, 2007
Effect of comorbid anxiety on treatment response in bipolar depressionMauricio Tohen, Joseph Calabrese, Eduard Vieta, et al.
The American Journal of Psychiatry|October 2, 2015
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in DepressionD Jeffrey Newport, Linda L Carpenter, William M McDonald, et al.
The American Journal of Psychiatry|January 5, 2021
Neuroimaging Biomarkers in SchizophreniaNina V Kraguljac, William M McDonald, Alik S Widge, et al.
Current Medical Research and Opinion|September 12, 2007
Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine toolsJamie Karagianis, Michael Rosenbluth, Mauricio Tohen, et al.
Bipolar Disorders|October 20, 2019
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 studyWillie R Earley, Maria V Burgess, Barbara Khan, et al.
Journal of Affective Disorders|July 28, 2007
The empirical redefinition of the psychometric criteria for remission in bipolar disorderMichael Berk, Felicity Ng, Wei V Wang, et al.
The Journal of Clinical Psychiatry|September 26, 2009
Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled studyJohn P Houston, Mauricio Tohen, Elisabeth K Degenhardt, et al.
Journal of Psychiatric Research|June 15, 2010
Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodesJohn P Houston, Terence A Ketter, Michael Case, et al.
Bipolar Disorders|May 29, 2016
Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD studyElizabeth D Ballard, Jennifer L Vande Voort, David A Luckenbaugh, et al.
Pageof 26